PORT WASHINGTON, N.Y., March 30, 2011 - Pall Corporation (NYSE: PLL) is launching an innovative solution for convenient and secure sterile separation of flexible tubing assemblies. The single-use Pall ...

Medical cleanrooms must have established protocols for processing medical device packaging from start to finish. In today's competitive market, many outsourcing companies claim to run top-of-the-line ...

At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...

Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. This agreement expands Lonza’s extensive offering of ...

Improving sterile supply management is one way hospitals can reduce the risk of infections and infection-related readmissions for their patients. Hospitals and other healthcare facilities may have ...

A technician at Microtest performs bioburden testing using the aseptic technique. There are no commonly accepted levels of environmental bioburden. Industrial sterilization and contamination control ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...